S Hettwer1, B Panzner-Grote, R Witthaut, K Werdan. 1. Martin-Luther-University, Halle-Wittenberg, Department of Medicine III, Ernst-Grube-Str. 40, 06097, Halle/Saale, Germany. stefan.hettwer@medizin.uni-halle.de
Abstract
INTRODUCTION: For diagnosis of diastolic dysfunction of the left ventricle (DDF), measurement of relaxation velocity (V(R)) by tissue Doppler imaging (V(R)), flow propagation velocity of transmitral inflow (v(p)) as well as the measurement of serum levels of N-terminal pro b-type natriuretic peptide (NT-proBNP) compete with the standard echocardiographic DDF-measures because of several disadvantages of the latter. METHODS: We examined the diagnostic value of method 1, 2 and NT-proBNP in 120 patients with echocardiographic-proven DDF and in 20 patients without. Patients were classified according to the DDF-stage by standard echocardiographic parameters (transmitral E/A-ratio, deceleration time, isovolumetric relaxation time) into stage I, II and III and furthermore subdivided by the presence of dyspnoea. RESULTS: V(R) and v(p) were significantly lower in patients with DDF than in patients without DDF, with no difference between the various DDF stages. Symptomatic patients showed a trend to a lower V(R). NT-proBNP was elevated in patients with DDF: Symptomatic patients with a DDF at stage I and patients with a DDF at stage II and III independent of the presence of symptoms had elevated NT-proBNP levels. CONCLUSION: All three methods tested identified patients with DDF. NT-proBNP and v(p) were able to discriminate between symptomatic and asymptomatic patients.
INTRODUCTION: For diagnosis of diastolic dysfunction of the left ventricle (DDF), measurement of relaxation velocity (V(R)) by tissue Doppler imaging (V(R)), flow propagation velocity of transmitral inflow (v(p)) as well as the measurement of serum levels of N-terminal pro b-type natriuretic peptide (NT-proBNP) compete with the standard echocardiographic DDF-measures because of several disadvantages of the latter. METHODS: We examined the diagnostic value of method 1, 2 and NT-proBNP in 120 patients with echocardiographic-proven DDF and in 20 patients without. Patients were classified according to the DDF-stage by standard echocardiographic parameters (transmitral E/A-ratio, deceleration time, isovolumetric relaxation time) into stage I, II and III and furthermore subdivided by the presence of dyspnoea. RESULTS: V(R) and v(p) were significantly lower in patients with DDF than in patients without DDF, with no difference between the various DDF stages. Symptomatic patients showed a trend to a lower V(R). NT-proBNP was elevated in patients with DDF: Symptomatic patients with a DDF at stage I and patients with a DDF at stage II and III independent of the presence of symptoms had elevated NT-proBNP levels. CONCLUSION: All three methods tested identified patients with DDF. NT-proBNP and v(p) were able to discriminate between symptomatic and asymptomatic patients.
Authors: Dennis A Tighe; Craig S Vinch; Jeffrey C Hill; Theo E Meyer; Robert J Goldberg; Gerard P Aurigemma Journal: Am J Cardiol Date: 2003-01-15 Impact factor: 2.778
Authors: Ehud Schwammenthal; Bogdan A Popescu; Andreea C Popescu; Elio Di Segni; Victor Guetta; Shmuel Rath; Michael Eldar; Micha S Feinberg Journal: Am J Cardiol Date: 2004-08-15 Impact factor: 2.778
Authors: M A García-Fernández; J Azevedo; M Moreno; J Bermejo; N Pérez-Castellano; P Puerta; M Desco; C Antoranz; J A Serrano; E García; J L Delcán Journal: Eur Heart J Date: 1999-04 Impact factor: 29.983
Authors: P Brun; C Tribouilloy; A M Duval; L Iserin; A Meguira; G Pelle; J L Dubois-Rande Journal: J Am Coll Cardiol Date: 1992-08 Impact factor: 24.094
Authors: Paolo Barbier; Antonio Grimaldi; Marina Alimento; Giovanni Berna; Maurizio D Guazzi Journal: Am J Cardiol Date: 2002-09-15 Impact factor: 2.778
Authors: Claudius Jacobshagen; Theresa Pelster; Anja Pax; Wiebke Horn; Stephan Schmidt-Schweda; Bernhard W Unsöld; Tim Seidler; Stephan Wagner; Gerd Hasenfuss; Lars S Maier Journal: Clin Res Cardiol Date: 2010-02-04 Impact factor: 5.460
Authors: Marc Licker; Mustafa Cikirikcioglu; Cidgem Inan; Vanessa Cartier; Afksendyios Kalangos; Thomas Theologou; Tiziano Cassina; John Diaper Journal: Crit Care Date: 2010-06-03 Impact factor: 9.097
Authors: Y M Hummel; I J T Klip; R M de Jong; P G Pieper; D J van Veldhuisen; A A Voors Journal: Clin Res Cardiol Date: 2010-03-10 Impact factor: 5.460
Authors: Thomas Butz; C Piper; C Langer; M Wiemer; T Kottmann; A Meissner; G Plehn; H J Trappe; D Horstkotte; L Faber Journal: Clin Res Cardiol Date: 2010-01-06 Impact factor: 5.460